Megan Fuller
Canada's Michael Smith Genome Sciences Centre(CA)Michigan State University(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, MicroRNA in disease regulation, Developmental Biology and Gene Regulation, Epigenetics and DNA Methylation, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer(2011)172 cited
- → Notch Initiates the Endothelial-to-Mesenchymal Transition in the Atrioventricular Canal through Autocrine Activation of Soluble Guanylyl Cyclase(2011)160 cited
- → Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling(2012)79 cited
- → Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma(2019)70 cited
- → SASH1 Is a Scaffold Molecule in Endothelial TLR4 Signaling(2013)63 cited
- → Loss of the Notch effector RBPJ promotes tumorigenesis(2014)58 cited
- → APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner(2017)58 cited
- → EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk(2013)56 cited
- → Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice(2020)55 cited
- → miR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signaling(2018)45 cited